|
UA80120C2
(en)
|
2002-03-26 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Glucocorticoid mimetics, pharmaceutical composition based thereon
|
|
ATE467616T1
(de)
*
|
2003-04-11 |
2010-05-15 |
High Point Pharmaceuticals Llc |
Verbindungen mit aktivität an der 11beta- hydroxasteroiddehydrogenase
|
|
SE0301232D0
(sv)
*
|
2003-04-25 |
2003-04-25 |
Astrazeneca Ab |
Novel use
|
|
UY28526A1
(es)
|
2003-09-24 |
2005-04-29 |
Boehringer Ingelheim Pharma |
Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
|
|
US7563905B2
(en)
|
2004-03-12 |
2009-07-21 |
Wyeth |
Triazole derivatives and method of using the same to treat HIV infections
|
|
US7795272B2
(en)
|
2004-03-13 |
2010-09-14 |
Boehringer Ingelheim Pharmaceutical, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
|
|
NZ551077A
(en)
|
2004-05-07 |
2009-05-31 |
Janssen Pharmaceutica Nv |
Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
|
US20060063930A1
(en)
*
|
2004-08-20 |
2006-03-23 |
Agoston Gregory E |
Compositions and methods comprising proteinase activated receptor antagonists
|
|
BRPI0515121A
(pt)
*
|
2004-08-30 |
2008-07-08 |
Janssen Pharmaceutica Nv |
derivados da n-2 adamantil-2-fenóxi acetamida como inibidores da 11-beta hidroxiesteróide desidrogenase
|
|
DE602005017159D1
(de)
|
2004-08-30 |
2009-11-26 |
Janssen Pharmaceutica Nv |
Oxysteroid-dehydrogenase-inhibitoren
|
|
MY141198A
(en)
|
2004-08-30 |
2010-03-31 |
Janssen Pharmaceutica Nv |
Tricyclic adamantylamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
|
US20090036484A1
(en)
*
|
2004-10-29 |
2009-02-05 |
Astrazeneca Ab |
Use of Unsaturated Quionoline or Naphtalene Derivatives as Medicaments
|
|
WO2006055760A1
(en)
|
2004-11-18 |
2006-05-26 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
|
PE20060776A1
(es)
|
2004-12-27 |
2006-09-26 |
Boehringer Ingelheim Pharma |
Mimeticos de glucocorticoides, metodos para prepararlos y composiciones farmaceuticas
|
|
DK1928840T3
(da)
|
2005-04-05 |
2011-09-12 |
Hoffmann La Roche |
1H-pyrazol-4-carboxamider, deres fremstilling og deres anvendelse som 11-beta-hydroxysteroid-dehydrogenaseinhibitorer
|
|
EP1889842A4
(en)
*
|
2005-06-08 |
2009-07-29 |
Japan Tobacco Inc |
HETEROCYCLIC CONNECTION
|
|
CN101248041B
(zh)
*
|
2005-06-17 |
2013-11-20 |
艾宝奇生物工艺有限公司 |
鞘氨醇激酶抑制剂
|
|
WO2007094819A2
(en)
|
2005-08-18 |
2007-08-23 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
|
US7622492B2
(en)
|
2005-08-31 |
2009-11-24 |
Hoffmann-La Roche Inc. |
Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
|
|
TW200734313A
(en)
*
|
2006-01-17 |
2007-09-16 |
Astrazeneca Ab |
Piperazines and piperidines as mGluR5 potentiators
|
|
BRPI0710479A2
(pt)
|
2006-01-18 |
2012-08-14 |
Hoffmann La Roche |
composto, processo para sua preparaÇço, composiÇço farmacÊutica, uso de um composto e mÉtodo de tratamento de doenÇa ou desosrdem metabàlica.
|
|
EP1999114B1
(en)
|
2006-03-22 |
2015-07-22 |
F. Hoffmann-La Roche AG |
Pyrazoles as 11-beta-hsd-1
|
|
EP1998760A2
(en)
*
|
2006-03-30 |
2008-12-10 |
James E. Summerton |
Non peptidic molecules for detecting and treating tumors
|
|
RU2303597C1
(ru)
*
|
2006-05-12 |
2007-07-27 |
Иващенко Андрей Александрович |
Фармацевтическая композиция, способы ее получения и применения
|
|
AU2007267843B2
(en)
|
2006-05-25 |
2011-10-13 |
Synta Pharmaceuticals Corp. |
Method for treating proliferative disorders associated with protooncogene products
|
|
US8183384B2
(en)
|
2006-05-25 |
2012-05-22 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate HSP90 activity
|
|
KR20090047450A
(ko)
|
2006-08-04 |
2009-05-12 |
메르츠 파마 게엠베하 운트 코. 카가아 |
치환된 피라졸로피리미딘, 이의 제조 방법 및 의약품으로서의 이의 용도
|
|
US8115005B2
(en)
|
2006-08-04 |
2012-02-14 |
Decode Genetics Ehf. |
Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation
|
|
US7727978B2
(en)
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
JP2010501567A
(ja)
|
2006-08-24 |
2010-01-21 |
ノバルティス アクチエンゲゼルシャフト |
代謝系、心血管系および他の障害の処置のためのステアロイル−ＣｏＡ不飽和化酵素（ＳＣＤ）阻害剤としての２−（ピラジン−２−イル）−チアゾールおよび２−（１Ｈ−ピラゾール−３−イル）チアゾール誘導体ならびに関連化合物
|
|
WO2008029168A2
(en)
*
|
2006-09-08 |
2008-03-13 |
Summit Corporation Plc |
Treatment of duchenne muscular dystrophy
|
|
KR20090053923A
(ko)
|
2006-09-22 |
2009-05-28 |
노파르티스 아게 |
헤테로시클릭 유기 화합물
|
|
EP2079491B1
(en)
*
|
2006-10-17 |
2013-02-27 |
Reva Medical, Inc. |
N-substituted monomers and polymers
|
|
EP2102170A2
(en)
|
2006-12-06 |
2009-09-23 |
Boehringer Ingelheim International GmbH |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
CN101595105B
(zh)
|
2006-12-20 |
2013-01-23 |
诺瓦提斯公司 |
作为scd抑制剂的2-取代的5元杂环化合物
|
|
ZA200904916B
(en)
|
2007-02-23 |
2010-09-29 |
High Point Pharmaceuticals Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
EP2125704A1
(en)
|
2007-02-23 |
2009-12-02 |
High Point Pharmaceuticals, LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
JP2010519239A
(ja)
|
2007-02-23 |
2010-06-03 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
１１−ベータ−ヒドロキシステロイドデヒドロゲナーゼの阻害因子としてのｎ−アドマンチルベンザミド
|
|
CA2681582C
(en)
|
2007-03-30 |
2015-07-14 |
Amgen Inc. |
Methods of treating bowel disorders
|
|
WO2008121126A1
(en)
*
|
2007-03-30 |
2008-10-09 |
Summerton James E |
Non-peptidic molecules for detecting and treating tumors
|
|
US20090215778A1
(en)
*
|
2007-04-27 |
2009-08-27 |
Panacos Pharmaceuticals, Inc. |
Alpha-substituted Arylmethyl Piperazine Pyrazolo [1,5-alpha]Pyrimidine Amide Derivatives
|
|
AU2008277783B2
(en)
|
2007-07-17 |
2012-09-20 |
F. Hoffmann-La Roche Ag |
Inhibitors of 11beta-hydroxysteroid dehydrogenase
|
|
US20100317863A1
(en)
*
|
2007-07-25 |
2010-12-16 |
Boehringer Ingelheim International Gmbh |
Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof
|
|
US8119658B2
(en)
|
2007-10-01 |
2012-02-21 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
FR2929851B1
(fr)
*
|
2008-04-09 |
2012-11-30 |
Centre Nat Rech Scient |
Molecules inhibant une voie metabolique impliquant la proteine tyrosine kinase syk et procede d'identification de ces molecules
|
|
CA2726449A1
(en)
|
2008-06-06 |
2009-12-10 |
Boehringer Ingelheim International Gmbh |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
PT2350075E
(pt)
|
2008-09-22 |
2014-06-09 |
Array Biopharma Inc |
Compostos imidazo[1,2b]piridazina substituídos como inibidores da trk cinase
|
|
US8536185B2
(en)
*
|
2008-09-22 |
2013-09-17 |
Cayman Chemical Company, Incorporated |
Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases
|
|
AR074052A1
(es)
|
2008-10-22 |
2010-12-22 |
Array Biopharma Inc |
Compuestos pirazolo{1,5-a}pirimidina sustituida como inhibidores de trk cinasa
|
|
WO2010047982A1
(en)
|
2008-10-22 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
JP5557845B2
(ja)
|
2008-10-31 |
2014-07-23 |
メルク・シャープ・アンド・ドーム・コーポレーション |
糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体
|
|
JP2012509879A
(ja)
|
2008-11-21 |
2012-04-26 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
アダマンチルベンズアミド化合物
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
EP2491030B1
(en)
*
|
2009-10-22 |
2015-07-15 |
Fibrotech Therapeutics PTY LTD |
Fused ring analogues of anti-fibrotic agents
|
|
US8895596B2
(en)
|
2010-02-25 |
2014-11-25 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
US9205086B2
(en)
|
2010-04-19 |
2015-12-08 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor
|
|
NZ604708A
(en)
|
2010-05-20 |
2015-05-29 |
Array Biopharma Inc |
Macrocyclic compounds as trk kinase inhibitors
|
|
AU2011202542A1
(en)
*
|
2010-07-14 |
2012-02-02 |
Indian Institute Of Science |
Benzothiophene carboxamide compounds, composition and applications thereof
|
|
FR2962649B1
(fr)
*
|
2010-07-19 |
2025-10-24 |
Conservatoire Nat Arts Et Metiers |
Traitement d'une pathologie liee a un effet excessif du tnf par un compose de benzene sulfonamide
|
|
US8513430B2
(en)
|
2010-07-27 |
2013-08-20 |
High Point Pharmaceuticals, Llc |
Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta HSD1 modulators
|
|
BR112013021236B1
(pt)
|
2011-02-25 |
2021-05-25 |
Merck Sharp & Dohme Corp |
composto derivado de benzimidazol, e, composição
|
|
EP2773345A1
(en)
|
2011-11-02 |
2014-09-10 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
|
|
AU2012332424A1
(en)
|
2011-11-02 |
2014-06-05 |
Synta Pharmaceuticals Corp. |
Combination therapy of Hsp90 inhibitors with platinum-containing agents
|
|
WO2013074594A1
(en)
|
2011-11-14 |
2013-05-23 |
Synta Pharmaceuticals Corp. |
Combination therapy of hsp90 inhibitors with braf inhibitors
|
|
US8889730B2
(en)
|
2012-04-10 |
2014-11-18 |
Pfizer Inc. |
Indole and indazole compounds that activate AMPK
|
|
JO3407B1
(ar)
*
|
2012-05-31 |
2019-10-20 |
Eisai R&D Man Co Ltd |
مركبات رباعي هيدرو بيرازولو بيريميدين
|
|
US9527875B2
(en)
|
2012-08-02 |
2016-12-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
US10092574B2
(en)
|
2012-09-26 |
2018-10-09 |
Valorisation-Recherche, Limited Partnership |
Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof
|
|
RU2015140066A
(ru)
|
2013-02-22 |
2017-03-30 |
Мерк Шарп И Доум Корп. |
Противодиабетические бициклические соединения
|
|
EP2968094B1
(en)
|
2013-03-13 |
2018-05-30 |
Unilever PLC |
Photoprotective compositions with tricyclodecane amides
|
|
US9775793B2
(en)
|
2013-03-13 |
2017-10-03 |
Conopco, Inc. |
Prolonged delivery of certain fragrance components from personal care compositions
|
|
WO2014139963A1
(en)
|
2013-03-13 |
2014-09-18 |
Unilever Plc |
Cosmetic compositions with tricyclodecane amides
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
JP6064062B2
(ja)
|
2013-03-15 |
2017-01-18 |
ファイザー・インク |
Ａｍｐｋを活性化させるインダゾール化合物
|
|
CN103420931B
(zh)
*
|
2013-05-02 |
2015-07-08 |
范国煌 |
调节巨噬细胞极化并抗糖尿病的五环化合物及其应用
|
|
GB201317363D0
(en)
|
2013-10-01 |
2013-11-13 |
Eisai Ltd |
Novel compounds
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
CA2930085C
(en)
|
2013-12-09 |
2021-11-02 |
Unilever Plc |
Process of making adamantanamides
|
|
US9381171B2
(en)
|
2013-12-19 |
2016-07-05 |
Samsung Electronics Co., Ltd. |
Composition including dapsone for preventing or treating side effect of steroid in subject and use of the composition
|
|
PE20211782A1
(es)
|
2014-05-23 |
2021-09-08 |
Hoffmann La Roche |
Compuestos de 5-cloro-2-difluorometoxifenil pirazolopirimidina, composiciones y metodos de uso de los mismos
|
|
KR102529578B1
(ko)
|
2014-08-29 |
2023-05-09 |
(주)아모레퍼시픽 |
신규 아다만탄 유도체 화합물
|
|
MX2017005462A
(es)
|
2014-11-05 |
2017-07-28 |
Flexus Biosciences Inc |
Agentes inmunorreguladores.
|
|
UY36390A
(es)
*
|
2014-11-05 |
2016-06-01 |
Flexus Biosciences Inc |
Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
|
|
HUE061448T2
(hu)
|
2014-11-16 |
2023-07-28 |
Array Biopharma Inc |
(S)-N-(5-((R)-2-(2,5-difluorofenil)-pirrolidin-1-il)-pirazolo[1,5-A]pirimidin-3-il) -3-hidroxipirrolidin-1-karboxamid-hidrogénszulfát kristályos formája
|
|
CN108697708A
(zh)
|
2015-10-26 |
2018-10-23 |
洛克索肿瘤学股份有限公司 |
Trk抑制剂抗性癌症中的点突变以及与此相关的方法
|
|
CN108602775B
(zh)
|
2016-01-14 |
2022-04-29 |
贝思以色列女会吏医学中心公司 |
肥大细胞调节剂及其用途
|
|
ES2987474T3
(es)
|
2016-04-04 |
2024-11-15 |
Loxo Oncology Inc |
Formulaciones líquidas de (S)-N-(5-((R)-2-(2,5-difluorofenil)-pirrolidin-1-IL)-pirazolo[1,5-A]pirimidin-3-IL)-3-hidroxipirrolidina-1-carboxamida
|
|
US10045991B2
(en)
|
2016-04-04 |
2018-08-14 |
Loxo Oncology, Inc. |
Methods of treating pediatric cancers
|
|
ES2836222T3
(es)
|
2016-05-18 |
2021-06-24 |
Loxo Oncology Inc |
Preparación de (S)-N-(5-((R)-2-(2,5-difluorofenil)pirrolidin-1-il)pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidina-1-carboxamida
|
|
JOP20190092A1
(ar)
|
2016-10-26 |
2019-04-25 |
Array Biopharma Inc |
عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
|
|
WO2018086531A1
(zh)
*
|
2016-11-08 |
2018-05-17 |
正大天晴药业集团股份有限公司 |
作为cccDNA抑制剂的磺酰胺类化合物
|
|
JP7595413B2
(ja)
|
2016-11-30 |
2024-12-06 |
ケース ウエスタン リザーブ ユニバーシティ |
１５－ｐｇｄｈ阻害剤とコルチコステロイドおよび／またはｔｎｆ阻害剤との組み合わせならびにその使用
|
|
US11072602B2
(en)
|
2016-12-06 |
2021-07-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
WO2018118670A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
|
WO2018145080A1
(en)
|
2017-02-06 |
2018-08-09 |
Case Western Reserve University |
Compositions and methods of modulating short-chain dehydrogenase activity
|
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
|
CA3059255A1
(en)
|
2017-04-07 |
2018-10-11 |
Case Western Reserve University |
Inhibitors of short-chain dehydrogenase activity for treating coronary disorders
|
|
WO2018215389A1
(en)
|
2017-05-22 |
2018-11-29 |
F. Hoffmann-La Roche Ag |
Therapeutic compounds and compositions, and methods of use thereof
|
|
CN120463721A
(zh)
|
2018-11-21 |
2025-08-12 |
卡斯西部储备大学 |
调节短链脱氢酶活性的组合物和方法
|
|
EP3906026A4
(en)
|
2018-12-31 |
2022-10-19 |
Biomea Fusion, LLC |
IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION
|
|
TW202043205A
(zh)
|
2018-12-31 |
2020-12-01 |
美商拜歐米富士恩有限公司 |
Menin-mll相互作用之抑制劑
|
|
JP7730807B2
(ja)
*
|
2019-09-04 |
2025-08-28 |
エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ |
β－カテニン／ＴＣＦ４相互作用のモジュレーターとしての複素環化合物
|
|
CN114845709B
(zh)
|
2019-11-05 |
2024-10-01 |
德米拉公司 |
用于治疗炎性病症的mrgprx2拮抗剂
|
|
EP4055011A1
(en)
*
|
2019-11-05 |
2022-09-14 |
Dermira, Inc |
Mrgprx2 antagonists and uses thereof
|
|
AU2022325861A1
(en)
|
2021-08-11 |
2024-02-29 |
Biomea Fusion, Inc. |
Covalent inhibitors of menin-mll interaction for diabetes mellitus
|
|
IL310717A
(en)
|
2021-08-20 |
2024-04-01 |
Biomea Fusion Inc |
Crystalline form of N-[4-[4-(4-morpholinyl)-7H-PYRROLO[2,3-D]PYRIMIDIN-6-YL]PHENYL]-4-[[3(R)-[(1-OXO ] -2-PROPEN-1-YL)AMINO]-1-PIPERIDINYL]METHYL]-2-PYRIDINECARBOXAMIDE, IRREVERSIBLE MENIN-MLL INHIBITOR FOR CANCER TREATMENT
|
|
WO2024155710A1
(en)
|
2023-01-18 |
2024-07-25 |
Biomea Fusion, Inc. |
Crystalline forms of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6- yl]phenyl]-4-[[3(r)-[(l-oxo-2-propen-l-yl)amino]-l-piperidinyl]methyl]-2-pyridinecarboxamide as a covalent inhibitor of menin-mll interaction
|
|
KR102863193B1
(ko)
*
|
2023-03-13 |
2025-09-22 |
대구가톨릭대학교산학협력단 |
리도카인 유도체를 유효성분으로 포함하는 항염증용 조성물
|
|
EP4458358A1
(en)
*
|
2023-05-02 |
2024-11-06 |
Tietze Chemical Consulting UG |
Pyridazine compounds for antifibrotic therapy
|
|
CN119219638A
(zh)
*
|
2023-06-29 |
2024-12-31 |
湖南九典制药股份有限公司 |
一种吡唑并杂芳基类化合物及其制备方法和应用
|
|
WO2025213050A1
(en)
*
|
2024-04-05 |
2025-10-09 |
Albert Einstein College Of Medicine |
Inhibitors of chaperone-mediated autophagy and their therapeutic uses
|